Filter Results:
(87)
Show Results For
- All HBS Web (345)
- Faculty Publications (138)
Show Results For
- All HBS Web (345)
- Faculty Publications (138)
Sort by
- 01 Dec 2019
- News
The Race Against Resistance
and cancer. Antibiotics helped lift the average life expectancy at birth from 54 years in 1920 to 78.6 today. But almost as soon as the treatments were made available, physicians had to cope with the specter of antibiotic resistance, a... View Details
Keywords: Lisa Scanlon Mogolov
- 15 Dec 2024
- News
After Ozempic
Wegovy as a treatment to reduce the risk of potentially deadly cardiovascular events. A study published in May found that Ozempic could significantly lower the risk of complications from chronic kidney disease. Then in July, researchers... View Details
- 01 Sep 2008
- News
Mara Aspinall
change that. Going forward, we need to view diagnostics, devices, and drugs in terms of the objective value that each creates. What about patient attitudes? Do you think most health-care consumers are ready to place their faith in View Details
- 01 Jan 2009
- News
Kathryn E. Giusti, MBA 1985
organization, the Multiple Myeloma Research Consortium, have revolutionized cancer research. Under her leadership, the two groups have made incredible progress — including helping to bring patients four new treatments — and continue to... View Details
- 07 Oct 2014
- News
Network Effect
after, because more genes with which to work would mean more avenues to explore in new drug development, exponentially increasing the chances of finding effective treatment and prevention. In 2004, the three... View Details
Keywords: Linda Kush
- 30 Sep 2022
- News
Scaling Hope
son’s life and D’Antonio’s. Today, both men work in the addiction treatment industry. D’Antonio’s son, now with more than six years continuous sobriety, is trained as a peer recovery coach, supporting others struggling with addiction.... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
tone quality, it was nothing short of a nightmare. After exhausting other treatment options, Frisch chose a radical alternative: having tiny, needle-like electrodes placed inside his brain. Those electrodes are part of a device called... View Details
Keywords: Janelle Nanos
- 20 Aug 2014
- News
With No Time to Lose
development and realized two things: First, without industry involvement there can’t be a treatment for ALS, because developing a single drug costs hundreds of millions of dollars. Second, that View Details
Keywords: Margie Kelley
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care. Porter and his colleagues aim to... View Details
- 11 May 2021
- News
Pitching to Win
the five grand-prize winners. Goble is co-founder of Karivez Bio, a platform for transforming chronic disease treatment through improved drug delivery. Okrah is founder and CEO of Chaku Foods, a fast-moving... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
president and CEO of Cytokinetics, Inc., a California-based company that focuses on biology-driven treatments for amyotrophic lateral sclerosis (ALS) and other debilitating diseases associated with muscle weakness. In 2015, the ALS... View Details
- 01 Sep 2004
- News
A Market-Based Prescription
and nephrologist. In a focused factory, all these resources are integrated. These diabetic specialists jointly develop treatment protocols and pricing. Together, they offer a full range of services customized for this disease. Research... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
until we make sure that the treatments and services consumers are getting are effective and affordable, changing the way we consumers pay for the services doesn’t fix anything. What we need is a system of new value networks that will... View Details
- 01 Jun 2018
- News
Floor It
The sci-fi future for cancer treatment has become a reality, with breakthrough therapies that can use a cancer patient’s genetic information to create personalized treatments or employ the body’s immune... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's... View Details
Keywords: Julia Hanna
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on View Details
- 01 Sep 2004
- News
Bill Dunaway (MBA 1964)
A self-described SOB — son of the boss — Bill Dunaway grew up working in his father’s pharmacy in Marietta, Georgia, a town of 61,000 outside Atlanta. After expanding the business to a chain of 18 drug stores, Dunaway sold the operation... View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
Cytokinetics, Inc., a South San Francisco–based company that focuses on treatments for debilitating diseases that compromise muscle function, such as amyotrophic lateral sclerosis (ALS), heart failure, and spinal muscular atrophy.... View Details
Keywords: Deborah Blagg